— Know what they know.
Not Investment Advice

MEDH OTC

MedX Holdings, Inc.
1W: +0.0% 1M: -13.3% 3M: -27.8% YTD: +85.7% 1Y: +30.0%
$0.00
+0.00 (+0.00%)
 
OTC · Consumer Defensive · Tobacco · Tech Score Neutral · Power 53 · $146011 mcap · 102M float · 0.964% daily turnover · Short 81% of daily vol

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 50 Grade B
Profitability
40
Balance Sheet
27
Earnings Quality
90
Growth
76
Value
74
Momentum
90
Safety
0
Cash Flow
53
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. MEDH scores highest in Earnings Quality (90/100) and lowest in Safety (0/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
-0.09
Distress Zone
Piotroski F-Score
5/9
✓ ✓ ✓ ✗ ✗ ✗ ✗ ✓ ✓
Beneish M-Score
-1.67
Possible Manipulator
Ohlson O-Score
-5.43
Bankruptcy prob: 0.4%
Low Risk
Credit Rating
CCC
Score: 18.6/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 0.92x
Accruals: 0.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. MEDH scores -0.09, placing it in the Distress Zone (safe > 2.99, distress < 1.81). Historically, companies in this range face elevated bankruptcy risk. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. MEDH scores 5/9, indicating moderate financial health — some areas of strength offset by weaknesses in others. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. MEDH's score of -1.67 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. MEDH's implied 0.4% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. MEDH receives an estimated rating of CCC (score: 18.6/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). MEDH's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
2.60x
PEG
0.02x
P/S
0.08x
P/B
0.16x
P/FCF
1.67x
P/OCF
1.64x
EV/EBITDA
16.05x
EV/Revenue
3.12x
EV/EBIT
16.48x
EV/FCF
20.91x
Earnings Yield
65.82%
FCF Yield
59.95%
Shareholder Yield
0.00%
Graham Number
$0.01
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 2.6x earnings, MEDH trades at a deep value multiple. An earnings yield of 65.8% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $0.01 per share, suggesting a potential 564% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.842
NI / EBT
×
Interest Burden
1.028
EBT / EBIT
×
EBIT Margin
0.189
EBIT / Rev
×
Asset Turnover
0.156
Rev / Assets
×
Equity Multiplier
1.887
Assets / Equity
=
ROE
4.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. MEDH's ROE of 4.8% is driven by a balanced combination of operating margin, asset efficiency, and leverage.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$0.00
Price/Value
0.18x
Margin of Safety
82.12%
Premium
-82.12%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with MEDH's realized 0.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. At an intrinsic value of $0.00, MEDH appears undervalued with a 82% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 2.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 534 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$0.00
Median 1Y
$0.00
5th Pctile
$0.00
95th Pctile
$0.00
Ann. Volatility
541.1%
25th–75th percentile 5th–95th percentile Median path Historical

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
John Walpuck Financial
and Chief Financial Officer
$128,750 $— $378,655
Howard Lieber President,
ior Vice President, Sales
$100,000 $— $312,931
Michael Fay Operating
ief Operating Officer
$89,583 $— $185,054
JW Roth
Chief Executive Officer
$100,000 $— $119,992
J. Glen House
Chief Medical Officer
$88,269 $— $100,088

CEO Pay Ratio

0:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $119,992
Avg Employee Cost (SGA/emp): $374,333
Employees: 30

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
30
-14.3% YoY
Revenue / Employee
$25,072
Rev: $752,152
Profit / Employee
$-360,467
NI: $-10,814,000
SGA / Employee
$374,333
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
ROE -0.7% -5.1% -4.1% -5.6% -6.4% -3.0% -0.9% 2.8% 4.8% 4.83%
ROA -0.4% -2.8% -2.2% -3.0% -3.5% -1.6% -0.5% 1.5% 2.6% 2.56%
ROIC -0.3% -2.1% -2.4% -2.4% -2.0% 0.7% 1.2% 2.1% 2.6% 2.58%
ROCE -0.4% -2.4% -1.8% -2.5% -3.0% -1.4% -0.1% 1.4% 3.0% 3.05%
Gross Margin 58.0% 63.0% 62.5% 63.4% 58.0% 63.3% 68.0% 66.8% 75.9% 75.90%
Operating Margin -42.6% -2.3% -34.6% 0.5% 4.2% 35.0% 10.5% 17.1% 17.4% 17.39%
Net Margin -43.5% -2.4% 57.2% -39.7% -35.4% -14.3% 50.3% 26.9% 4.3% 4.25%
EBITDA Margin -41.1% -1.9% 62.8% -34.4% -31.3% -11.9% 54.5% 17.7% 17.9% 17.95%
FCF Margin -14.7% -8.0% -18.7% -22.0% -27.7% -4.5% -6.4% 8.3% 14.9% 14.90%
OCF Margin -14.7% -8.0% -18.7% -22.0% -27.7% -4.5% -6.4% 8.6% 15.1% 15.13%
ROE 3Y Avg snapshot only -0.86%
ROA 3Y Avg snapshot only -0.45%
ROIC 3Y Avg snapshot only -0.26%
ROIC Economic snapshot only 2.58%
Cash ROA snapshot only 2.32%
Cash ROIC snapshot only 2.39%
CROIC snapshot only 2.35%
NOPAT Margin snapshot only 16.34%
Pretax Margin snapshot only 19.43%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 49.79%
SBC / Revenue snapshot only 0.00%
Valuation
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
P/E Ratio -3.41 -0.49 -0.60 -1.54 -1.52 -5.57 -8.47 3.46 1.52 2.600
P/S Ratio 1.48 0.71 0.48 0.98 0.84 1.04 0.36 0.39 0.25 0.077
P/B Ratio 0.02 0.02 0.02 0.09 0.10 0.17 0.07 0.10 0.07 0.155
P/FCF -10.12 -8.90 -2.57 -4.43 -3.03 -23.19 -5.66 4.75 1.67 1.668
P/OCF — — — — — — — 4.60 1.64 1.643
EV/EBITDA -117.76 -19.41 -26.20 -20.19 -17.78 -43.68 -1041.87 35.91 16.05 16.047
EV/Revenue 48.41 23.31 15.80 9.98 7.74 6.48 4.62 3.83 3.12 3.116
EV/EBIT -113.62 -19.13 -25.50 -19.69 -17.41 -41.98 -501.81 37.65 16.48 16.477
EV/FCF -330.16 -290.68 -84.60 -45.27 -27.99 -143.94 -71.93 46.18 20.91 20.914
Earnings Yield -29.3% -2.1% -1.7% -64.8% -65.8% -17.9% -11.8% 28.9% 65.8% 65.82%
FCF Yield -9.9% -11.2% -38.9% -22.6% -33.0% -4.3% -17.7% 21.1% 59.9% 59.95%
PEG Ratio snapshot only 0.021
EV/OCF snapshot only 20.599
EV/Gross Profit snapshot only 4.502
Acquirers Multiple snapshot only 16.046
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $0.01
Leverage & Solvency
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Current Ratio 0.95 0.22 0.52 0.48 0.43 0.17 0.28 0.25 0.26 0.262
Quick Ratio 0.77 0.02 0.37 0.36 0.33 0.07 0.14 0.18 0.20 0.201
Debt/Equity 0.74 0.78 0.77 0.80 0.83 0.89 0.86 0.84 0.83 0.828
Net Debt/Equity 0.74 0.78 0.77 0.80 0.83 0.89 0.86 0.84 0.83 0.826
Debt/Assets 0.42 0.43 0.42 0.43 0.44 0.45 0.45 0.45 0.44 0.441
Debt/EBITDA -114.15 -18.82 -25.43 -18.23 -15.90 -36.77 -964.91 32.33 14.79 14.794
Net Debt/EBITDA -114.15 -18.82 -25.41 -18.22 -15.85 -36.65 -959.85 32.22 14.77 14.767
Interest Coverage — -16.00 -9.58 -8.93 -7.87 -4.69 -0.27 1.97 2.98 2.979
Equity Multiplier 1.79 1.82 1.83 1.87 1.90 1.98 1.92 1.88 1.88 1.875
Cash Ratio snapshot only 0.017
Debt Service Coverage snapshot only 3.059
Cash to Debt snapshot only 0.002
FCF to Debt snapshot only 0.052
Defensive Interval snapshot only 8.3 days
Efficiency & Turnover
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Asset Turnover 0.01 0.02 0.03 0.05 0.06 0.08 0.11 0.13 0.16 0.156
Inventory Turnover 0.71 1.17 1.72 2.89 4.27 4.71 5.73 10.36 10.73 10.734
Receivables Turnover 0.38 — — — 5.40 887.99 219.73 326.50 327.03 327.030
Payables Turnover — — — — — 15.65 14.67 13.89 15.16 15.156
DSO 956 0 0 0 68 0 2 1 1 1.1 days
DIO 513 311 213 126 85 77 64 35 34 34.0 days
DPO 0 0 0 0 0 23 25 26 24 24.1 days
Cash Conversion Cycle 1469 311 213 126 153 55 40 10 11 11.0 days
Fixed Asset Turnover snapshot only 24.917
Operating Cycle snapshot only 35.1 days
Cash Velocity snapshot only 191.834
Capital Intensity snapshot only 6.509
Growth (YoY)
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Revenue — — — — 6.1% 3.6% 3.0% 1.8% 1.5% 1.53%
Net Income — — — — -8.0% 41.2% 78.8% 1.5% 1.7% 1.75%
EPS — — — — -8.0% 41.2% 78.8% 1.5% 1.7% 1.75%
FCF — — — — -12.4% -1.6% -36.3% 2.1% 2.4% 2.36%
EBITDA — — — — -6.5% 43.0% 97.1% 1.6% 2.1% 2.13%
Op. Income — — — — -5.3% 1.4% 1.5% 1.8% 2.3% 2.29%
OCF Growth snapshot only 2.38%
Asset Growth snapshot only 3.62%
Equity Growth snapshot only 5.01%
Debt Growth snapshot only 4.99%
Shares Change snapshot only 0.00%
Growth Quality
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Revenue Stability — — — — — — — — 0.97 0.974
Earnings Stability — — — — — — — — 0.24 0.242
Margin Stability — — — — — — — — 0.91 0.907
Rev. Growth Consistency 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.000
Earn. Growth Consistency 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0
Earnings Persistence — — — — — — — — 0.20 0.200
Earnings Smoothness — — — — — — — — — —
ROE Trend — — — — — — — — 0.08 0.084
Gross Margin Trend — — — — — — — — 0.10 0.097
FCF Margin Trend — — — — — — — — 0.36 0.361
Sustainable Growth Rate — — — — — — — 2.8% 4.8% 4.83%
Internal Growth Rate — — — — — — — 1.5% 2.6% 2.62%
Cash Flow Quality
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
OCF/Net Income 0.34 0.05 0.23 0.35 0.50 0.24 1.50 0.75 0.92 0.925
FCF/OCF 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.97 0.98 0.985
FCF/Net Income snapshot only 0.911
OCF/EBITDA snapshot only 0.779
CapEx/Revenue 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.3% 0.2% 0.23%
CapEx/Depreciation snapshot only 0.449
Accruals Ratio -0.00 -0.03 -0.02 -0.02 -0.02 -0.01 0.00 0.00 0.00 0.002
Sloan Accruals snapshot only -0.000
Cash Flow Adequacy snapshot only 66.462
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — 0.0% 0.0% 0.00%
FCF Payout Ratio — — — — — — — 0.0% 0.0% 0.00%
Total Payout Ratio — — — — — — — 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — —
Chowder Number — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -18.6% -14.0% -18.6% -18.65%
Total Shareholder Return 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -18.6% -14.0% -18.6% -18.65%
DuPont Factors
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.13 1.17 1.12 1.10 1.00 1.00 0.90 0.84 0.842
Interest Burden (EBT/EBIT) 1.02 1.07 1.11 1.12 1.13 1.21 4.66 1.24 1.03 1.028
EBIT Margin -0.43 -1.22 -0.62 -0.51 -0.44 -0.15 -0.01 0.10 0.19 0.189
Asset Turnover 0.01 0.02 0.03 0.05 0.06 0.08 0.11 0.13 0.16 0.156
Equity Multiplier 1.79 1.82 1.83 1.87 1.84 1.90 1.87 1.87 1.89 1.887
Per Share
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $0.00 $0.00 $0.00
Book Value/Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Tangible Book/Share $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01 $-0.01
Revenue/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
FCF/Share $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $0.00 $0.00 $0.00
OCF/Share $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $0.00 $0.00 $0.00
Cash/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EBITDA/Share $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $-0.00 $0.00 $0.00 $0.00
Debt/Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Net Debt/Share $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01 $0.01
Academic Models
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — -0.089
Altman Z-Prime snapshot only -0.750
Piotroski F-Score 2 2 2 2 4 5 4 5 5 5
Beneish M-Score — — — — -1.83 -0.29 -0.08 -1.32 -1.67 -1.674
Ohlson O-Score snapshot only -5.433
Net-Net WC snapshot only $-0.01
EVA snapshot only $-784173.51
Credit
Metric Trend Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q4'25 Q1'26 Current
Credit Rating snapshot only CCC
Credit Score 27.61 16.19 16.56 15.76 16.45 15.17 15.84 15.85 18.58 18.576
Credit Grade snapshot only 17
Credit Trend snapshot only 2.130
Implied Spread (bps) snapshot only 1200.000
Industry Credit Rank snapshot only 5
Sector Credit Rank snapshot only 8

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms